Table 3.
Site | Participant ID | Time to death (days) | Duration of corticosteroid use (days) | Duration of neuromuscular blocker use (days) | Duration of prone ventilation (days) |
---|---|---|---|---|---|
Duke | 1 | 7 | 5 | 4 | — |
Duke | 2 | — | 8 | — | — |
Duke | 3 | 39 | 5 | 17 | 6 |
Duke | 4 | — | 9 | — | — |
Duke | 5 | 76 | 10 | 6 | 1 |
Duke | 6 | 27 | 10 | 3 | — |
Duke | 7 | 20 | 9 | 7 | 1 |
Duke | 8 | — | 6 | . | — |
Baptist Health | 9 | — | — | 3 | — |
Baptist Health | 10 | — | — | 16 | 16 |
Median (range) | 27 (7.0, 76) | 9 (5, 10) | 6 (3, 17) | 4 (1, 16) |